Fed. Circ. Wary Of Undoing Endo Loss Over Vasostrict Fight

By Khorri Atkinson (July 7, 2022, 6:13 PM EDT) -- Two Federal Circuit judges on Thursday repeatedly pushed back on an Endo International unit's assertion that a Delaware federal judge erroneously declined to stop Eagle Pharmaceuticals Inc. from launching a generic version of blood pressure medication Vasostrict after finding that Endo's newer patents covering the blockbuster drug wouldn't be infringed. ...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!